Dr Eng Chon Boon is the co-lead of the Cancer Databases and Tissues Banks platform of the Singapore Translational Cancer Consortium. He is also the director for the Tissue Repository, National University Hospital (NUH), and runs the Hospital-based Cancer Registry (HCR) at the National University Cancer Institute (NCIS), and has an adjunct position in the Saw Swee Hock School of Public Health (SSHSPH), National University of Singapore (NUS). He is also the principal person-in-charge of tissue banks across the National University Health System (NUHS) public healthcare cluster, and the co-lead PI for the Singapore Integrated Network of Biorepositories (SINB), an infrastructure network formed by academic tissue repositories in Singapore. He is the Singapore’s convenor for ISO//TC276 Biotechnology and in the editorial board of “Biopreservation and Biobanking” by Mary Ann Liebert.
He is a past recipient for International Society for Biological and Environmental Repositories (ISBER) special service award (2010) and had numerous voluntary responsibilities within the ISBER over the years (Councilor, Chair of the ISBER Marketing Committee, members of ISBER Finance, Nominating, Strategic Planning, Program Committee), vice-chair of local organizing committee for the 2007 ISBER Annual Meeting in Singapore. Currently, he is also a member of the advisory panel for Biosample Hub, a not-for-profit company that helps industry requesters to partner with academic providers. He has numerous publications/book chapter/patent in the field of biobanking and had given talks, conducted biobanking workshops and consulted for various international biobanks over the past 15 years.
For a list of biobanking activities and further info, please refer to the following:
Platform Lead, Cancer Databases & Tissue Banks, Singapore Translational Cancer Consortium;
Senior Consultant (Medical Oncology), National Cancer Centre Singapore (NCCS);
Director of Research, Clinical Analytics, Division of Medical Oncology, NCCS, Singhealth;
Senior Clinician Scientist, Genome Institute of Singapore, A*Star
Assoc. Professor Iain Tan is a Senior Consultant Medical Oncologist, leading the colorectal cancer service in the GI Oncology Team at the Department of Medical Oncology, National Cancer Centre Singapore. He co- chairs Singhealth’s multidisciplinary colorectal cancer tumor board. Nationally, he chairs the Medical Oncology Exit Exam committee for specialist accreditation & is a member of MOH’s research training review panel & NMRC’s grant review panel. At NCCS, he is also the clinical chair for NCCS’s luminal GI cancer Comprehensive Research Program. Concurrently, he is a clinician scientist at Genome Institute of Singapore and an assistant professor at Duke-NUS. His research focuses –on metastases and drug resistance and immune-oncology in gastrointestinal cancers, with a special interest in non-invasive diagnostics & innovative early phase clinical trials. He has published widely, with many first or corresponding authorpublications in leading journals including Journal of Clinical Oncology, Nature Medicine, Nature Genetics, Science Translational Medicine and Lancet Oncology. For his research, he has received the ASCO Young Investigator Award (2010) and ASCO Merit Award (2011) and Singhealth Distinguished Young Researcher Award. For his clinical service & research, he received the Singapore Youth Award in 2014, the country’s highest award for youths.